6505--Ropinirole Tablet

The Department of Veterans Affairs National Acquisition Center is soliciting offers for the supply of Ropinirole HCL tablets in multiple strengths (0.25mg to 5mg) and package sizes (100-tablet and 500-tablet bottles) through a single firm fixed-price contract. The solicitation requires offerors to submit prices for 13 line items covering all dosage strengths and quantities for both the one-year base ordering period and all four one-year priced options to be considered for award. Award will be made to the lowest-priced, technically acceptable offeror, with mandatory requirements including FDA current Good Manufacturing Practice compliance, submission of a unique 11-digit National Drug Code number, product registration with the FDA and various pharmaceutical databases within five calendar days of award, and compliance with specific packaging standards including safety caps, bar coding per GS1-128 or HIBCC standards, and Drug Supply Chain Security Act serialization requirements. All offered prices must include a 0.5% Cost Recovery Fee and cannot exceed two decimal places. The offer due date is April 30, 2026, at 2:30 PM CT.

This solicitation has no set-aside designation and does not identify any current contractors or incumbents. The total estimated annual usage across all government participants is approximately 154,000 bottles, with the contract serving the Department of Veterans Affairs, Department of Defense, Indian Health Service, Bureau of Prisons, Captain James A. Lovell Federal Health Care Center, and State Veteran Homes through their respective Pharmaceutical Prime Vendor programs. While a specific award value is not provided in the solicitation documents, the volume of 154,000 bottles annually across five years (base plus options) indicates a substantial procurement. Contractors must submit quarterly sales reports, register offered products with First Databank, Oracle Cerner/Multum, and Medispan, and are prohibited from assigning payment rights under the contract. Non-manufacturer offerors must provide a Letter of Commitment from the manufacturer as part of their proposal submission.